Tokyo Stock Exchange

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO)

Retrieved on: 
Wednesday, April 3, 2024
Harvard Medical School, Dana–Farber Cancer Institute, GBM, Code, Glioblastoma, Clinical trial, Society, Brigham and Women's Hospital, Hospital, Tokyo Stock Exchange, ASCO, Neuro-Oncology (journal), Annual general meeting

LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding results of a clinical trial of MN-166 (ibudilast) in glioblastoma (GBM) has been selected for an oral presentation at the American Society of Clinical Oncology (2024 ASCO) Annual Meeting to be held May 31 – June 4, 2024 in Chicago.

Key Points: 
  • LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding results of a clinical trial of MN-166 (ibudilast) in glioblastoma (GBM) has been selected for an oral presentation at the American Society of Clinical Oncology (2024 ASCO) Annual Meeting to be held May 31 – June 4, 2024 in Chicago.
  • The oral presentation will be presented by one of the investigators of this clinical trial, Gilbert Youssef, M.D., Attending Physician at Harvard Medical School, Center for Neuro-Oncology at Dana-Farber Cancer Institute and Brigham and Women's Hospital.
  • The presentation details are as follows:

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

Retrieved on: 
Tuesday, March 26, 2024
OCT, Optical coherence tomography, Patent, Multiple sclerosis, Capsule, Tablet, Code, MD, SPRINT, MPH, Tokyo Stock Exchange, Pharmaceutical industry

Once issued, this patent is expected to expire no earlier than October 2039.

Key Points: 
  • Once issued, this patent is expected to expire no earlier than October 2039.
  • The allowed claims cover the use of MN-166 (ibudilast) for treating macular injury associated with progressive multiple sclerosis and for decreasing macular volume loss associated with progressive multiple sclerosis.
  • The allowed claims specifically cover both primary progressive multiple sclerosis and secondary progressive multiple sclerosis.
  • Previously, we reported positive Optical Coherence Tomography (OCT) results from the SPRINT-MS Phase 2b trial of MN-166 in progressive multiple sclerosis.

Moomoo Japan Offers Japanese Stock Trading Services, Further Upgrading its Features to Serve Local Investors

Retrieved on: 
Monday, April 8, 2024
Attention, Apple, NISA, Muumuu, Osaka Exchange, Nikkei, Real estate investment trust, Zorg, Tokyo Stock Exchange, ETF

TOKYO, April 8, 2024 /PRNewswire/ -- Moomoo Japan has introduced Japanese stock trading services, allowing investors in Japan to seamlessly trade both US and domestic stocks using moomoo, a global investment and trading platform which was officially introduced to Japan in September last year.

Key Points: 
  • TOKYO, April 8, 2024 /PRNewswire/ -- Moomoo Japan has introduced Japanese stock trading services, allowing investors in Japan to seamlessly trade both US and domestic stocks using moomoo, a global investment and trading platform which was officially introduced to Japan in September last year.
  • Following the successful launch of US stock trading in Japan, Moomoo Japan is taking a step further to diversify its offerings to deliver upgraded trading experience for local investors.
  • The prolonged period of low-interest rates in recent years has ignited a surge in interest among investors for stock investments.
  • To cater to the robust investment demand from Japanese investors and offer them a wider range of trading options, moomoo launched Japanese stock trading offering," said Francisco Izawa, President of Moomoo Securities Japan.

MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society

Retrieved on: 
Wednesday, March 20, 2024
Congress, Juntendo University, Dyslipidemia, Patient, SAFETY, Research, Code, MD, Abstract, Type 2 diabetes, HTG, Tokyo Stock Exchange, EAS, Lipid metabolism, NAFLD, T2DM, Pharmaceutical industry

Presentation details will be disseminated as they become available.

Key Points: 
  • Presentation details will be disseminated as they become available.
  • Ph.D., M.P.H., Chief Medical Officer, MediciNova, Inc., commented, “We are very pleased that the two presentations were accepted at the EAS 2024 Congress.
  • One presentation is regarding the objectives and design of the ongoing Phase 2 clinical trial enrolling patients with Type 2 diabetes, dyslipidemia, and NAFLD.
  • The other presentation is regarding the mechanism of action of MN-001/MN-002 in lipid metabolism, particularly the effects on cholesterol efflux capacity.

MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology

Retrieved on: 
Tuesday, March 12, 2024
Abstract, Chlorine, Survival, SOT, University, Doctor of Philosophy, MD, Code, FAHA, Society, Translation, Safety, Tokyo Stock Exchange, ALI, Edema

In this study, single-dose and multi-dose treatments were evaluated.

Key Points: 
  • In this study, single-dose and multi-dose treatments were evaluated.
  • The primary endpoint was the mean change in the pulmonary function measure PaO2/FiO2, which is the ratio of arterial oxygen partial pressure to fractional inspired oxygen.
  • Additional endpoints included survival, lung mechanics, lung injury, and edema formation evaluated by chest x-ray.
  • Cl2 gas concentration of 210 ppm x 30 min was expected to result in a 20 - 30% mortality rate (Fukuda 2015).

Soracom Listed on the Tokyo Stock Exchange Growth Market

Retrieved on: 
Tuesday, March 26, 2024
Technology, Mobile, Wireless, Satellite, Telecommunications, Software, Networks, Internet, IOT (Internet of Things), Data Management, Tokyo Stock Exchange, LPWA, Internet of things, Agriculture, Glass, DX, Mobile phone

Soracom, Inc., a global provider of advanced connectivity for the Internet of Things (IoT), today announced that it has listed its shares on the Growth Market of the Tokyo Stock Exchange.

Key Points: 
  • Soracom, Inc., a global provider of advanced connectivity for the Internet of Things (IoT), today announced that it has listed its shares on the Growth Market of the Tokyo Stock Exchange.
  • Soracom currently connects millions of devices worldwide, and the cloud-native Soracom IoT connectivity platform provides a single pane of glass for management and control of various types of IoT connections, including cellular, LPWA, and satellite.
  • Soracom will continue to pursue technology innovation and further business growth as a global IoT platform, accelerate our customers’ ability to deliver new connected services and products at scale, and develop the business and technology partnerships that will build a better, more connected future.
  • Soracom’s founders, board, and staff are grateful today to all of the stakeholders who have supported us since our founding, above all our past, present, and future customers and partners.

FACEWHITE Completes Pre-A Funding and Continues Strong Push into Overseas Markets with Chinese Content

Retrieved on: 
Tuesday, April 2, 2024
Film & Motion Pictures, Entertainment, Licensing (Entertainment), Online, IPS, Tokyo City, Once, White snake, Academy Awards, The King's Speech, COMMUNICATION, MOVIC, Fox Spirit Matchmaker, GAGA, Outcast, Good Smile Company, Animation, LIVE, Investment, EE Limited, Viva la Vida, The King's Avatar, Legend, Tokyo Stock Exchange, La La Land, Sapphire, Film industry

recently completed its Pre-A financing round, with investments coming from three prominent Japanese companies: HANABARA CORPORATION, GAGA CORPORATION, and HORIPRO GROUP HOLDINGS.

Key Points: 
  • recently completed its Pre-A financing round, with investments coming from three prominent Japanese companies: HANABARA CORPORATION, GAGA CORPORATION, and HORIPRO GROUP HOLDINGS.
  • Founded in 2013 and registered in 2018, the brand name "Garden" has now been one of the top domestic production companies of animation series and movies.
  • The company has long been dedicated to promoting and distributing Chinese IPs overseas.
  • Utilizing the funds raised in this financing round, the company will continue to push its distribution and merchandise licensing sales, recruit talent, and further enhance the expansion of Chinese cultural content in Japan and other overseas markets.

THine Releases to Launch AI Server Business in Addition to LSI and AIOT Business

Retrieved on: 
Monday, March 18, 2024
Other Manufacturing, Mobile, Wireless, Technology, Semiconductor, Software, Manufacturing, Hardware, Data Management, IOT (Internet of Things), Artificial Intelligence, THine Electronics, Research, Fujitsu, AI, Hyperdata, Electronics, Thou, LSI, Tokyo Stock Exchange

THine Electronics, Inc. (Tokyo Stock Exchange: 6769, “THine”), the global leader in high-speed serial interface and provider of mixed-signal LSI as well as valuable AI/IoT-based solution, today releases to launch its data server business to enhance its business synergy and efficiency in addition to its semiconductor and AI/IoT business.

Key Points: 
  • THine Electronics, Inc. (Tokyo Stock Exchange: 6769, “THine”), the global leader in high-speed serial interface and provider of mixed-signal LSI as well as valuable AI/IoT-based solution, today releases to launch its data server business to enhance its business synergy and efficiency in addition to its semiconductor and AI/IoT business.
  • In order to contribute to further utilization of generative AI and AI research in Japan, THine has decided to provide data servers, including AI servers equipped with NVIDIA’s GPUs.
  • THine’s new server business will provide:
    and develop software, systems and solutions related to the above, etc.
  • THine plans to establish its new subsidiary, THine HyperData, Inc., on April 1st, 2024 in Yokohama, Japan with the following representatives:
    Chairman and CEO: Takashi Nakahara, the board member of THine, and the Founder and CEO of THine’s AIOT subsidiary
    President: Kenji Mizuno, the President of Fujitsu Isotec Limited until March 31st, 2024
    “It is our great pleasure to support and accelerate the AI utilization and AI research in Japan,” said Dr. Takashi Nakahara, Chief Architect Officer of THine, “THine HyperData plans to achieve its sales of 1 billion yen or more in FY2028, accelerating its business by collaboration just like THine’s AIOT business does.”

"JAPAN BULLET TRAIN" Shinkansen Ticket Service Now Open to International Travelers and Foreign Residents in Japan

Retrieved on: 
Tuesday, March 12, 2024
Tokyo Stock Exchange, WeChat Pay, QR, Narita Express, Travel, Shinkansen, Apple Pay, Platform, Rail transport

Through the "JAPAN BULLET TRAIN" website provided by the company, accessible via the link below, international travelers and foreign residents can effortlessly book and manage Shinkansen tickets in less than 2 minutes, while also eliminating language barriers and ensuring seamless experience.

Key Points: 
  • Through the "JAPAN BULLET TRAIN" website provided by the company, accessible via the link below, international travelers and foreign residents can effortlessly book and manage Shinkansen tickets in less than 2 minutes, while also eliminating language barriers and ensuring seamless experience.
  • -Inbound Platform Corp. known for its diverse range of travel services catering to international travelers and foreign residents, has decided to expand and extend support by facilitating Shinkansen ticket bookings.
  • Recognizing the complexities, time constraints and language barriers involved in purchasing Shinkansen tickets, the company aims to streamline the entire booking process through the new service.
  • With a commitment to exceptional customer service, the company offers telephone assistance in seven languages for a flawless travel experience.

"JAPAN BULLET TRAIN" Shinkansen Ticket Service Now Open to International Travelers and Foreign Residents in Japan

Retrieved on: 
Tuesday, March 12, 2024
Tokyo Stock Exchange, WeChat Pay, QR, Narita Express, Travel, Shinkansen, Apple Pay, Platform, Rail transport

Through the "JAPAN BULLET TRAIN" website provided by the company, accessible via the link below, international travelers and foreign residents can effortlessly book and manage Shinkansen tickets in less than 2 minutes, while also eliminating language barriers and ensuring seamless experience.

Key Points: 
  • Through the "JAPAN BULLET TRAIN" website provided by the company, accessible via the link below, international travelers and foreign residents can effortlessly book and manage Shinkansen tickets in less than 2 minutes, while also eliminating language barriers and ensuring seamless experience.
  • -Inbound Platform Corp. known for its diverse range of travel services catering to international travelers and foreign residents, has decided to expand and extend support by facilitating Shinkansen ticket bookings.
  • Recognizing the complexities, time constraints and language barriers involved in purchasing Shinkansen tickets, the company aims to streamline the entire booking process through the new service.
  • With a commitment to exceptional customer service, the company offers telephone assistance in seven languages for a flawless travel experience.